Maurizio Raiteri
#123,901
Most Influential Person Now
Maurizio Raiteri's AcademicInfluence.com Rankings
Maurizio Raiterimedical Degrees
Medical
#1941
World Rank
#2329
Historical Rank
Pharmacology
#193
World Rank
#233
Historical Rank
Download Badge
Medical
Why Is Maurizio Raiteri Influential?
(Suggest an Edit or Addition)Maurizio Raiteri's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International Union of Pharmacology. XXXIII. Mammalian γ-Aminobutyric AcidB Receptors: Structure and Function (2002) (539)
- A simple apparatus for studying the release of neurotransmitters from synaptosomes. (1974) (451)
- Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. (1979) (407)
- Carrier-mediated release of neurotransmitters (1993) (378)
- Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. (1984) (311)
- Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants (2010) (263)
- International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. (2002) (254)
- Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. (1988) (240)
- Multiple GABAB receptors. (1993) (230)
- Chronic Antidepressants Reduce Depolarization-Evoked Glutamate Release and Protein Interactions Favoring Formation of SNARE Complex in Hippocampus (2005) (228)
- Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. (1986) (223)
- Serotonin release is modulated by presynaptic autoreceptors. (1979) (222)
- Presynaptic kynurenate‐sensitive receptors inhibit glutamate release (2001) (208)
- Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. (1977) (208)
- Direct evidence that release‐stimulating α7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals (2002) (206)
- Synaptosomes Still Viable after 25 Years of Superfusion (2000) (195)
- Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers (1988) (179)
- Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptake (1974) (171)
- In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway (1999) (164)
- d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. (1975) (144)
- Subthalamic stimulation activates internal pallidus: Evidence from cGMP microdialysis in PD patients (2005) (134)
- Nerve growth factor and brain‐derived neurotrophic factor increase neurotransmitter release in the rat visual cortex (1998) (126)
- Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release. (1983) (123)
- Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. (1990) (120)
- RELEASE AND EXCHANGE STUDIES RELATING TO THE SYNAPTOSOMAL UPTAKE OF GABA (1975) (120)
- Detectability of high and low affinity uptake systems for GABA and glutamate in rat brain slices and synaptosomes. (1973) (120)
- Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. (1986) (119)
- Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease (2006) (117)
- 5‐Hydroxytryptamine3 Receptors Sited on Cholinergic Axon Terminals of Human Cerebral Cortex Mediate Inhibition of Acetylcholine Release (1992) (114)
- N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. (1992) (112)
- Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors. (1989) (111)
- Cyclo‐oxygenase‐1 and ‐2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N‐methyl‐d‐aspartate receptors in rat hippocampus (2005) (111)
- Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? (1984) (111)
- Autoregulation of acetylcholine release in isolated hippocampal nerve endings. (1981) (104)
- Studies on [3H]GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type. (1987) (102)
- On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties. (1985) (100)
- Monitoring of cyclic GMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity (1993) (94)
- Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes (2002) (85)
- Nicotine administration stimulates the in vivo N‐methyl‐D‐aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release (1998) (85)
- GABA and glutamate uptake by subcellular fractions enriched in synaptosomes: critical evaluation of some methodological aspects. (1973) (83)
- GABAB receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats (2000) (81)
- Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex. (1992) (80)
- In vivo activation of N‐methyl‐d‐aspartate receptors in the rat hippocampus increases prostaglandin E2 extracellular levels and triggers lipid peroxidation through cyclooxygenase‐mediated mechanisms (2002) (80)
- Acetylcholine release from rat hippocampal slices is modulated by 5-hydroxytryptamine. (1989) (80)
- Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors. (1988) (79)
- Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex (1997) (79)
- Presynaptic muscarinic receptors increase striatal dopamine release evoked by "quashi-physiological" depolarization. (1982) (77)
- Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein (2006) (75)
- N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal. (1992) (73)
- gamma-Aminobutyric acid (GABA) autoreceptors in rat cerebral cortex and spinal cord represent pharmacologically distinct subtypes of the GABAB receptor. (1993) (71)
- CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. (1993) (71)
- Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus (2007) (71)
- Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity (1994) (69)
- Release of Catecholamines, Serotonin, and Acetylcholine from Isolated Brain Tissue (1984) (67)
- Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices (2003) (67)
- The functional recovery of damaged brain: The effect of GM1 monosialoganglioside (1984) (67)
- Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine. (1993) (67)
- Age‐related Changes in the NMDA Receptor/Nitric Oxide/cGMP Pathway in the Hippocampus and Cerebellum of Freely Moving Rats Subjected to Transcerebral Microdialysis (1995) (65)
- Effect of desmethylimipramine on the release of (3H)norepinephrine induced by various agents in hypothalamic synaptosomes. (1977) (64)
- Serotonin 5‐HT1D and 5‐HT1A Receptors Respectively Mediate Inhibition of Glutamate Release and Inhibition of Cyclic GMP Production in Rat Cerebellum In Vitro (1996) (64)
- Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release. (1989) (62)
- Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release (2005) (62)
- Entrapping of Impermeant Probes of Different Size into Nonpermeabilized Synaptosomes as a Method to Study Presynaptic Mechanisms (2000) (62)
- Multiple mechanisms of transmitter release evoked by ‘pathologically’ elevated extracellular [K+]: involvement of transporter reversal and mitochondrial calcium (2002) (61)
- Supersensitivity of central noradrenergic presynaptic autoreceptors following chronic treatment with the antidepressant mianserin. (1981) (60)
- Alpha 2-adrenoceptors in rat hypothalamus and cerebral cortex: functional evidence for pharmacologically distinct subpopulations. (1985) (60)
- Ectocellular in vitro and in vivo metabolism of cADP-ribose in cerebellum. (1996) (59)
- Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release (2004) (59)
- Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes (1976) (58)
- Release of endogenous glutamic and aspartic acids from cerebrocortex synaptosomes and its modulation through activation of a γ-aminobutyric acidB (GABAB) receptor subtype (1993) (58)
- Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons (2002) (58)
- N‐methyl‐D‐aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier‐mediated release of glutamate in rat hippocampus (2007) (58)
- Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes. (1994) (58)
- Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization. (1990) (58)
- RANTES Modulates the Release of Glutamate in Human Neocortex (2008) (57)
- Functional Pharmacology in Human Brain (2006) (57)
- Serotonin autoreceptor in rat hippocampus: Pharmacological characterization as a subtype of the 5-HT1 receptor (1986) (56)
- Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function (1997) (56)
- Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices. (1991) (56)
- Electrophysiology and Pharmacology of Striatal Neuronal Dysfunction Induced by Mitochondrial Complex I Inhibition (2008) (56)
- Somatostatin potentiates NMDA receptor function via activation of InsP3 receptors and PKC leading to removal of the Mg2+ block without depolarization (2000) (55)
- Synaptosomal transport processes. (1976) (54)
- Release‐regulating autoreceptors of the GABAB‐type in human cerebral cortex (1989) (54)
- Regional differences in the synaptosomal uptake of 3H-gamma-aminobutyric acid and 14C-glutamate and possible role of exchange processes. (1974) (53)
- Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord (2008) (53)
- Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+ concentrations (2007) (52)
- Pre‐synaptic glycine GlyT1 transporter – NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions (2011) (52)
- Deep brain stimulation in Parkinson's disease patients: biochemical evidence. (2006) (51)
- GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. (2000) (51)
- Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum. (1986) (51)
- Muscarinic receptors mediate direct inhibition of GABA release from rat striatal nerve terminals (1990) (51)
- 5-HT2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals. (1991) (50)
- Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes (1989) (50)
- Subclassification of release‐regulating α2‐autoreceptors in human brain cortex (1992) (50)
- The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-d-aspartate receptors mediating noradrenaline release in the hippocampus (1998) (50)
- Presynaptic autoreceptors (2001) (50)
- Release of cholecystokinin in the central nervous system (1993) (49)
- Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings (1982) (49)
- Modulation of gamma-aminobutyric acid transport in nerve endings: role of extracellular gamma-aminobutyric acid and of cationic fluxes. (1978) (49)
- Oxiracetam increases the release of endogenous glutamate from depolarized rat hippocampal slices. (1990) (48)
- GABA terminal autoreceptors in the pars compacta and in the pars reticulata of the rat substantia nigra are GABAB. (1990) (48)
- In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. (1995) (47)
- Presynaptic metabotropic glutamate and GABAB receptors. (2008) (47)
- Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120 (1996) (46)
- Endogenous aspartate release in the rat hippocampus is inhibited by M2 'cardiac' muscarinic receptors. (1990) (46)
- Do presynaptic auto-receptors control dopamine release? (1978) (45)
- Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co‐expressed on rat and human noradrenergic terminals (2007) (45)
- P2X7 receptors exert a permissive role on the activation of release-enhancing presynaptic α7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals (2006) (45)
- Somatostatin-Induced Activation and Up-Regulation of N-Methyl-d-aspartate Receptor Function: Mediation through Calmodulin-Dependent Protein Kinase II, Phospholipase C, Protein Kinase C, and Tyrosine Kinase in Hippocampal Noradrenergic Nerve Endings (2005) (44)
- The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings. (2010) (44)
- Microdialysis in Parkinsonian Patient Basal Ganglia: Acute Apomorphine-Induced Clinical and Electrophysiological Effects Not Paralleled by Changes in the Release of Neuroactive Amino Acids (2001) (43)
- GABA(B) receptors as potential targets for drugs able to prevent excessive excitatory amino acid transmission in the spinal cord. (1998) (42)
- Functional 'glial' GLYT1 glycine transporters expressed in neurons. (2010) (42)
- The NOS/sGC pathway in the rat central nervous system: a microdialysis overview (2004) (42)
- Release‐regulating GABAA receptors are present on noradrenergic nerve terminals in selective areas of the rat brain (1987) (41)
- Glutamic Acid and γ‐Aminobutyric Acid Modulate Each Other's Release Through Heterocarriers Sited on the Axon Terminals of Rat Brain (1993) (40)
- (−)-Propranolol and (±)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain (1987) (40)
- Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons (1997) (40)
- Release-regulating presynaptic heterocarriers (1994) (40)
- The Human Immunodeficiency Virus-1 Protein Transactivator of Transcription Up-Regulates N-Methyl-d-aspartate Receptor Function by Acting at Metabotropic Glutamate Receptor 1 Receptors Coexisting on Human and Rat Brain Noradrenergic Neurones (2006) (39)
- Modulation of the function of presynaptic α7 and non‐α7 nicotinic receptors by the tryptophan metabolites, 5‐hydroxyindole and kynurenate in mouse brain (2006) (39)
- Release‐enhancing pre‐synaptic muscarinic and nicotinic receptors co‐exist and interact on dopaminergic nerve endings of rat nucleus accumbens (2008) (39)
- Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals (2004) (38)
- Clonidine enhances the release of endogenous gamma-aminobutyric acid through alpha-2 and alpha-1 presynaptic adrenoceptors differentially located in rat cerebral cortex subregions. (1988) (38)
- Correction: Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants (2010) (37)
- d-amphetamine and the release of 3H-norepinephrine from synaptosomes. (1974) (37)
- Trafficking of presynaptic AMPA receptors mediating neurotransmitter release: Neuronal selectivity and relationships with sensitivity to cyclothiazide (2006) (36)
- Adaptation of presynaptic acetylcholine autoreceptors following long-term drug treatment. (1981) (36)
- Uptake, Exchange and Release of GABA in Isolated Nerve Endings (1978) (36)
- Trazodone is a potent agonist at 5-HT2C receptors mediating inhibition of the N-methyl-D-aspartate/nitric oxide/cyclic GMP pathway in rat cerebellum. (1998) (36)
- Studies on dopamine uptake and release in synaptosomes. (1978) (35)
- GABAergic nerve terminals in rat hippocampus possess α 2-adrenoceptors regulating GABA release (1987) (35)
- Benzodiazepine‐Sensitive GABAA Receptors Limit the Activity of the NMDA/NO/Cyclic GMP Pathway (2000) (34)
- Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A2A adenosine receptor blockade (2004) (33)
- Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors. (1993) (33)
- The Human Immunodeficiency Virus-1 Protein Tat and Its Discrete Fragments Evoke Selective Release of Acetylcholine from Human and Rat Cerebrocortical Terminals through Species-Specific Mechanisms (2003) (33)
- γ‐Aminobutyric Acid and Glycine Modulate Each Other's Release Through Heterocarriers Sited on the Releasing Axon Terminals of Rat CNS (1992) (33)
- Glycine stimulates [3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus. (1990) (33)
- Serotonin inhibits the depolarization-evoked release of endogenous glutamate from rat cerebellar nerve endings (1986) (32)
- N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation. (1992) (32)
- Is acetylcholine release from striatal nerve endings regulated by muscarinic autoreceptors? (1983) (31)
- Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels. (2005) (31)
- Low nanomolar serotonin inhibits the glutamate receptor/nitric oxide/cyclic GMP pathway in slices from adult rat cerebellum (1995) (31)
- Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABAB receptor antagonists (2001) (31)
- NK‐3 receptors mediate enhancement of substance P release from capsaicin‐sensitive spinal cord afferent terminals (1998) (31)
- GABAB autoreceptors in rat cortex synaptosomes: response under different depolarizing and ionic conditions. (1989) (30)
- Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists (2003) (30)
- In vivo microdialysis study of GABAA and GABaB receptors modulating the glutamate receptor/NO/ cyclic GMP pathway in the rat hippocampus (1997) (30)
- Noradrenaline inhibits central serotonin release through alpha2-adrenoceptors located on serotonergic nerve terminals (1982) (30)
- GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion. (1985) (30)
- Neurosteroids may differentially affect the function of two native GABAA receptor subtypes in the rat brain (1998) (30)
- Presence of a gamma-aminobutyric acid (GABA) uptake system on cholinergic terminals of rat hippocampus: evidence for neuronal coexistence of acetylcholine and GABA? (1987) (30)
- In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats (2008) (30)
- Depletion of Synaptosomal Neurotransmitter Pool by Sudden Cooling (1973) (29)
- Chronic clonidine induces functional down-regulation of presynaptic alpha 2-adrenoceptors regulating [3H]noradrenaline and [3H]5-hydroxytryptamine release in the rat brain. (1985) (29)
- Functional evidence that chronic drugs induce adaptive changes of central autoreceptors regulating serotonin release. (1984) (28)
- Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors. (1995) (28)
- Pirenzepine-insensitive muscarinic autoreceptors regulate acetylcholine release in human neocortex (1990) (27)
- GABAA, but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex (2004) (27)
- Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F (1999) (27)
- Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. (1994) (27)
- Uptake and exchange of GABA and glutamate in isolated nerve endings. (1976) (27)
- Selective block of rat and human neocortex GABAB receptors regulating somatostatin release by a GABAB antagonist endowed with cognition enhancing activity (1999) (26)
- Functional evidence for two native GABAA receptor subtypes in adult rat hippocampus and cerebellum (1996) (26)
- Phaclofen antagonizes GABA at autoreceptors regulating release in rat cerebral cortex. (1988) (26)
- The "kynurenate test", a biochemical assay for putative cognition enhancers. (1997) (26)
- Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors. (1989) (26)
- GABA FLUXES IN PRESYNAPTIC NERVE ENDINGS FROM IMMATURE RATS (1979) (26)
- Presynaptic regulation of acetylcholine release in the CNS. (1989) (25)
- In vitro release of somatostatin from cerebral cortical slices: characterization of electrically evoked release (1988) (25)
- A reevaluation of veratridine as a tool for studying the depolarization-induced release of neurotransmitters from nerve endings (1980) (25)
- Nicotinic receptors modulating ACh release in rat cortical synaptosomes: role of Ca2+ ions in their function and desensitization (1999) (25)
- Nicotine has a permissive role on the activation of metabotropic glutamate 5 receptors coexisting with nicotinic receptors on rat hippocampal noradrenergic nerve terminals (2006) (25)
- Glycine is taken up through GLYT1 and GLYT2 transporters into mouse spinal cord axon terminals and causes vesicular and carrier‐mediated release of its proposed co‐transmitter GABA (2001) (25)
- Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes (2002) (25)
- D-serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis (1996) (24)
- Dopamine biosynthesis is regulated by the amine newly recaptured by dopaminergic nerve endings. (1980) (24)
- Chronic drug treatments induce changes in the sensitivity of presynaptic autoreceptors but not of presynaptic heteroreceptors. (1983) (24)
- Dicyclomine- and pirenzepine-sensitive muscarinic receptors mediate inhibition of [3H]serotonin release in different rat brain areas. (1986) (23)
- Modulation of 5-hydroxytryptamine release by presynaptic inhibitory α2-adrenoceptors in the human cerebral cortex (1990) (23)
- GABA enhances acetylcholine release from hippocampal nerve endings through a mechanism blocked by a GABA uptake inhibitor (1986) (23)
- Regional Selectivity of a γ‐Aminobutyric Acid‐Induced [3H]Acetylcholine Release Sensitive to Inhibitors of γ‐Aminobutyric Acid Uptake (1987) (23)
- Enhancement of endogenous GABA release from rat synaptosomal preparations is mediated by α2-adrenoceptors pharmacologically different from α2-autoreceptors (1988) (23)
- Cellular mechanisms of the acute increase of glutamate release induced by nerve growth factor in rat cerebral cortex (2003) (23)
- Release of dopamine from human neocortex nerve terminals evoked by different stimuli involving extra‐ and intraterminal calcium (2000) (22)
- HIV‐1 Envelope Protein gp120 Potentiates NMDA‐evoked Noradrenaline Release by a Direct Action at Rat Hippocampal and Cortical Noradrenergic Nerve Endings (1994) (22)
- Antisynaptosome antibodies affect synaptosomal permeability to neurotransmitters. (1973) (21)
- NK3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats (2000) (21)
- Extracellular protons differentially potentiate the responses of native AMPA receptor subtypes regulating neurotransmitter release (2005) (21)
- Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. (2006) (21)
- Multiple functions of neuronal plasma membrane neurotransmitter transporters (2015) (21)
- Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices (1999) (20)
- Role of External and Internal Calcium on Heterocarrier‐Mediated Transmitter Release (1996) (20)
- Carriers for GABA and noradrenaline uptake coexist on the same nerve terminal in rat hippocampus. (1987) (20)
- Enhancement by GABA of glutamate depolarization-induced release from cerebellar nerve endings (1981) (20)
- In Vivo NO/cGMP Signalling in the Hippocampus (2001) (20)
- Release of Cholecystokinin‐Like Immunoreactivity in the Frontal Cortex of Conscious Rats as Assessed by Transcerebral Microdialysis: Effects of Different Depolarizing Stimuli (1993) (19)
- Increased Presynaptic Protein Kinase C Activity and Glutamate Release in Rats with a Prenatally Induced Hippocampal Lesion (1997) (19)
- Characteristics of dopamine release from isolated nerve endings of the tuberoinfundibular neurones (1981) (19)
- Somatostatin Release from Rat Cerebral Cortex Synaptosomes (1991) (19)
- Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis (2003) (19)
- Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG) (2013) (19)
- Cholinergic nerve terminals of human cerebral cortex possess a GABA transporter whose activation induces release of acetylcholine (1991) (19)
- Decrease of uptake and exchange of neurotransmitter amino acids after depletion of their synaptosomal pools (1976) (19)
- Inhibitory presynaptic 5-hydroxytryptamine(2A) receptors regulate evoked glutamate release from rat cerebellar mossy fibers. (2001) (17)
- Synaptosome antisera affect permeability of synaptosomal membranes in vitro. (1972) (16)
- Effects of oxiracetam on neurotransmitter release from rat hippocampus slices and synaptosomes (1992) (16)
- Vasoactive intestinal polypeptide (VIP) potentiates the muscarinic stimulation of phosphoinositide turnover in rat cerebral cortex. (1987) (16)
- Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors. (1996) (15)
- AMPA-evoked acetylcholine release from cultured spinal cord motoneurons and its inhibition by GABA and glycine (2001) (15)
- GABA(A), but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex. (2004) (14)
- Differential binding of antidepressants to noradrenaline and serotonin transport sites in central nerve endings. (1979) (14)
- gamma-Aminobutyric acidB receptors mediate inhibition of somatostatin release from cerebrocortex nerve terminals. (1991) (14)
- A Subtype of the γ-Aminobutyric AcidB Receptor Regulates Cholinergic Twitch Response in the Guinea Pig Ileum (2000) (14)
- Activation of γ‐aminobutyric acid GAT‐1 transporters on glutamatergic terminals of mouse spinal cord mediates glutamate release through anion channels and by transporter reversal (2005) (14)
- Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex. (1985) (14)
- Stimulus-coupled release of unmetabolized 3-H-norepinephrine from rat brain synaptosomes. (1975) (13)
- Heterocarrier-mediated reciprocal modulation of glutamate and glycine release in rat cerebral cortex and spinal cord synaptosomes. (1994) (13)
- Presynaptic muscarinic receptor activation enhances striatal dopamine release evoked by depolarization but not that induced by non-depolarizing stimuli (1985) (13)
- Clonidine differentially modulates the release of endogenous GABA in various rat brain areas. (1991) (13)
- Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: Control by presynaptic 5-HT1D receptors (2006) (13)
- Enhanced benzodiazepine and ethanol actions on cerebellar GABAA receptors mediating glutamate release in an alcohol-sensitive rat line (1999) (13)
- Activation of α6 GABAA receptors on depolarized cerebellar parallel fibers elicits glutamate release through anion channels (2001) (12)
- GABA transporters mediate glycine release from cerebellum nerve endings: Roles of Ca2+channels, mitochondrial Na+/Ca2+ exchangers, vesicular GABA/glycine transporters and anion channels (2012) (12)
- Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices. (1999) (12)
- Ionic dysregulations typical of ischemia provoke release of glycine and GABA by multiple mechanisms (2010) (12)
- Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis (2010) (12)
- Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine (1985) (11)
- Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis. (2005) (11)
- Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection (1989) (11)
- GABA potentiates the depolarization-induced release of glutamate from cerebellar nerve endings. (1981) (11)
- Glycine release provoked by disturbed Na+, K+ and Ca2+ homeostasis in cerebellar nerve endings: roles of Ca2+ channels, Na+/Ca2+ exchangers and GlyT2 transporter reversal (2011) (11)
- Release and exchange of neurotransmitters in synaptosomes: Effects of the ionophore A23187 and of ouabain (1976) (11)
- Functional studies of neurotransmitter receptors in human brain. (1994) (10)
- Presynaptic α2-adrenoceptors mediating inhibition of noradrenalh and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different α2-adrenoceptor subtynes (1992) (10)
- Inhibition by 5-HT3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats (2004) (10)
- Subclassification of release-regulating alpha 2-autoreceptors in human brain cortex. (1992) (9)
- gamma-Aminobutyric acid (GABA) stimulates somatostatin release following activation of a GABA uptake carrier located on somatostatin nerve endings of rat cerebral cortex. (1991) (9)
- Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity. (1980) (9)
- Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-d-aspartate and AMPA receptors (1997) (9)
- A carrier for GABA uptake exists on noradrenaline nerve endings in selective rat brain areas but not on serotonin terminals (2005) (9)
- Is the muscarinic receptor that mediates potentiation of dopamine release negatively coupled to the cyclic GMP system? (1987) (9)
- Energy in Einstein–Maxwell theory and the first law of isolated horizons via the Noether theorem (2002) (8)
- Release of biogenic amines from isolated nerve endings. (1976) (8)
- Enhancement of endogenous GABA release from rat synaptosomal preparations is mediated by alpha 2-adrenoceptors pharmacologically different from alpha 2-autoreceptors. (1988) (8)
- Specificity and cross-reactivity of antisynaptosome antibodies. (1974) (8)
- A nervous system specific protein potentiates the biological effects of the calcium ionophore A23187. (1980) (8)
- Intracerebral administration of l-kynurenine decreases N-methyl-d-aspartate receptor-mediated production of cGMP in the cerebellum and hippocampus of unanaesthetized rats subjected to transcerebral microdialysis (1999) (8)
- Pharmacologically distinct GABAB receptor subtypes modulate neurotransmitter release in the rat brain cortex. (1992) (7)
- Release of dopamine from striatal synaptosomes. (1978) (7)
- External pH changes affect NMDA-evoked and spontaneous release of cholecystokinin, somatostatin and noradrenaline from rat cerebrocortical nerve endings (2004) (7)
- [3]PIRENZEPINE BINDING IN RAT CORPUS STRIATUM DECREASES AFTER HEMITRANSECTION OF THE NIGRO‐STRIATAL PATHWAY (1987) (7)
- Evaluation of the mechanisms underlying the kainate-induced impairment of [3H]dopamine release in the rat striatum. (1993) (7)
- GABA(B) presynaptic receptors modulate glycine exocytosis from mouse spinal cord and hippocampus glycinergic nerve endings. (2009) (7)
- Characterization of two central AMPA-preferring receptors having distinct location, function and pharmacology (1994) (7)
- Co-existence of GABA and Glu transporters in the central nervous system. (2006) (7)
- Evidence for a functional coupling between dopamine reuptake and tyrosine hydroxylation in striatal nerve terminals (1982) (7)
- Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat (1992) (7)
- Benzodiazepine-sensitive GABA(A) receptors limit the activity of the NMDA/NO/cyclic GMP pathway: a microdialysis study in the cerebellum of freely moving rats. (2000) (7)
- Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes. (1992) (7)
- Diaminobutyric acid: A tool for discriminating between carrier-mediated and non-carrier-mediated release of GABA from synaptosomes? (1976) (6)
- GABAergic nerve terminals in rat hippocampus possess alpha 2-adrenoceptors regulating GABA release. (1987) (6)
- Calcium-dependent [3H]acetylcholine release and muscarinic autoreceptors in rat cortical synaptosomes during development (1983) (6)
- Studies on the release of exogenous and endogenous GABA and glutamate from rat brain synaptosomes (1981) (6)
- Mammalian-Aminobutyric AcidB Receptors : Structure and Function (2002) (6)
- Presynaptic glycine-dependent NMDA receptors mediate enhancement of the release of [3H]NA from noradrenergic terminals of rat hippocampus. (1992) (6)
- Gauge natural field theories and applications to conservation laws1 (2001) (5)
- Interaction between 5-HT uptake inhibition and activation of 5-HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes (1987) (5)
- Heterologous Carriers Located on Rat CNS Nerve Endings and their Possible Role in the Modulation of Transmitter Release (1988) (5)
- Effects of phenethylamine derivatives on the release of biogenic amines from synaptosomes. (1976) (5)
- Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration. (1992) (5)
- Differential blockade by (−)mianserin of the alpha2-adrenoceptors mediating inhibition of noradrenaline and serotonin release from rat brain synaptosomes (1983) (5)
- Intrastriatal kainic acid elicits functional supersensitivity of muscarinic receptors regulating dopamine release (1987) (5)
- Synaptosomes as a tool in the development of new neuroactive drugs. (1983) (5)
- Presynaptic autoreceptors control serotonin release from central nerve endings. (1980) (5)
- A subtype of the gamma-aminobutyric acid(B) receptor regulates cholinergic twitch response in the guinea pig ileum. (2000) (4)
- Effects of p-chloro-beta-phenylethylamine on the uptake and release of putative amine neurotransmitters in rat brain [proceedings]. (1976) (4)
- Evidence for a similar compartmentation of recaptured and endogenously synthesized dopamine in striatal synaptosomes (1980) (4)
- Serotonergic inhibition of the mossy fibre—granule cell glutamate transmission in rat cerebellar slices (1993) (4)
- A novel type of GABA receptor in rat spinal cord? (1989) (4)
- The activation of phosphatidylinositol turnover is not directly involved in the modulation of neurotransmitter release mediated by presynaptic muscarinic receptors (1988) (4)
- Absence of binding by botulinum toxin to isolated synaptosomal membranes. (1971) (4)
- Glycine enhances [3H]noradrenaline release from slices of rat hippocampus (1990) (4)
- Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype (1991) (4)
- A reinterpretation of tyramine sympathomimetic effect and tachyphylaxis (1986) (4)
- Effects of some atypical antidepressants on catecholamine synthesis and release. (1982) (3)
- Choline increases endogenous GABA release in rat hippocampus by a mechanism sensitive to hemicholinium-3 (1987) (3)
- Regional selectivity of a gamma-aminobutyric acid-induced [3H]acetylcholine release sensitive to inhibitors of gamma-aminobutyric acid uptake. (1987) (3)
- Release in vitro as a model to study neurotransmitter receptors. (1987) (3)
- Quantitative evaluation of antigen-antibody interactions at the external surface of the nerve ending membrane. (1973) (3)
- Presynaptic Receptors Modulating Transmitter Release: Physiological and Pharmacological Aspects (1992) (2)
- Effect of some quinolizidine derivatives on the release of serotonin, noradrenaline, dopamine and acetylcholine from rat brain synaptosomes. (1989) (2)
- Noradrenaline uptake inhibitors do not reduce the presynaptic action of clonidine on 3H-noradrenaline release in superfused synaptosomes (1984) (2)
- The HIV-1 viral protein Tat modulates glutamate and GABA exocytosis from human and mouse neocortical nerve endings by acting at different binding sites (2010) (2)
- Kainic acid injection impairs the autoregulation of dopamine release in rat striatum (1988) (2)
- Evidence for an autoreceptor-mediated presynaptic control of serotonin release in central nerve endings [proceedings]. (1979) (2)
- A Subtype of the g-Aminobutyric AcidB Receptor Regulates Cholinergic Twitch Response in the Guinea Pig Ileum 1 (2000) (2)
- Cholinergic modulation of [3H]dopamine release from dendrosomes of rat substantia nigra (1991) (2)
- Somatostatin-Induced Activation and Upregulation of NMDA Receptor Function: Mediation Through CaMKII, PLC, PKC and Src in Hippocampal Noradrenergic Nerve Endings (2004) (2)
- Effects of some rigid analogues of imipramine and amitriptyline on the uptake of noradrenaline, serotonin and choline in rat brain synaptosomes. (1982) (2)
- Alpha-adrenergic regulation of the GABA-endogenous release in different rat cerebral cortex subregions. (1990) (1)
- Effects of long-term drug treatments on the sensitivity of presynaptic receptors regulating neurotransmitter release. (1984) (1)
- Proceedings: Synaptosomal exchange of gamma-aminobutyric acid (GABA) can simulate high affinity uptake. (1974) (1)
- Facilitation of [3H]acetylcholine and [3H]5-hydroxytryptamine release from rat cerebral cortex synaptosomes by a factor extracted from the skin of the Australian frog Pseudophryne coriacea. (1989) (1)
- Serotonin Receptors Regulating Transmitter Release (1990) (1)
- Pharmacologically distinct release modulating subtypes of the GABAB receptor population (1992) (1)
- The GABA B receptor antagonists CGP35348 and CGP52432 inhibit glycine exocytosis: study with GABA B1- and GABA B2-deficient mice. (2010) (1)
- Interaction of beta-phenethylamine with dopamine and noradrenaline in the central nervous system of the rat. (1976) (1)
- Are neurotransmitter carriers cell-specific markers? (1992) (1)
- Regulation of Dopamine Release by Muscarinic Receptors (1988) (1)
- Presynaptic Cholinergic Mechanisms in Human Cerebral Cortex of Adult and Aged Patients (1991) (1)
- Coexistence of More Than One Neurotransmitter Uptake System on the Same Nerve Terminal in the Brain (1991) (1)
- Early Recovery of Striatal Dopamine Uptake in Rats with Unilateral Nigro-Striatal Lesion Following Treatment with Monosialoganglioside (1986) (1)
- Stereochemical interpretation of high oxygen affinity of haemoglobin Little Rock alpha-2beta-2 143His-Gln. (1973) (1)
- Dopamine: Spontaneous and drug-evoked release from presynaptic nerve endings of the tuberoinfundibular system (1981) (1)
- GM1 ganglioside treatment promotes recovery of electrically-stimulated [3H]dopamine release in striatal slices from rats lesioned with kainic acid (1992) (1)
- REPLY FROM DR. RAITERI (1988) (0)
- The Geometric Variational Framework for Entropy in General Relativity (2005) (0)
- GABA stimulates receptor-independently the release of somatostatin from rat cortical synaptosomes: Involvement of a GABA transport system (1990) (0)
- Leveling glutamate release: A presynaptic path toward antidepressant action (2005) (0)
- Glycine modulates 3H-noradrenaline release in rat hippocampus through a strychnine-sensitive receptor (1990) (0)
- Serotonin-Glutamate Interactions in Rat Cerebellum: Involvement of Multiple 5-HT Receptor Subtypes (1988) (0)
- Studies in vivo of the nitric oxide/cyclic GMP pathway in the brain (1998) (0)
- In vitro and in vivo modulation of nitric oxide synthesis in the rat cerebellum and hippocampus (2001) (0)
- The modulation of neurotransmitter release by muscarinic presynaptic receptors is not directly mediated by the activation of PI turnover (1988) (0)
- Human brain cortex nerve endings are endowed with GABA autoreceptors of the GABAB subtype (1988) (0)
- Biochemical Markers of DBS-Induced Transition from “Off” to “On” State in Parkinsonian Patients (2005) (0)
- In vivo studies of glutamatergic receptors and NO pathways in brain (2001) (0)
- In vivo studies of glutamatergic receptors and NO pathways in brain (2002) (0)
- Two different subtypes of M2 muscarinic receptors present onto rat hippocampus nerve endings modulate acetylcholine and glutamic acid release (1988) (0)
- Chronic antidepressants block the increase in depolarization-evoked release of glutamate induced by acute stress (2008) (0)
- Subtypes of the 5 hydroxytryptamine 1 receptor regulate tritiated 5 hydroxytryptamine and endogenous glutamate release in rat cerebellum (1986) (0)
- Effects of a parenteral treatment with GM1 monosialoganglioside inner ester on striatal 3H-DA uptake and 3H-DA release after lesioning the nigrostriatal pathways* (1988) (0)
- Release-regulating presynaptic GABAB receptors (1995) (0)
- In vivo investigation of the NMDA/NOS/CGMP pathway during aging in the hippocampus and cerebellum of freely-moving rats (1995) (0)
- N-metyl-D-aspartate stimulates cyclooxygenase-2-dependent release of prostaglandin E2 and isoprostane-F2 in the rat hippocampus: an in vivo microdialysis study (2001) (0)
- Modulation of gamma amino butyric acid transport in nerve endings developmental aspects (1980) (0)
- IN VIVO FUNCTIONAL CHARACTERIZATION OF PHOSPHODIESTERASE ISOFORMS DEGRADATING CYCLIC GMP IN THE CORTEX, HIPPOCAMPUS AND CEREBELLUM OF FREELY-MOVING RATS (2003) (0)
- Entropy for horizons in theories of gravitation (2004) (0)
- Release-regulating GABAB autoreceptors in rat cerebral cortex slices. (1989) (0)
- Serotonin-glutamate interaction in rat cerebellum: involvement of 5-hydroxytryptamine receptor subtypes. (1988) (0)
- Differential effects of “cold shock” on neuro-transmitter depletion in synaptosomes (1974) (0)
- Subtype of 5-HT1 receptor regulating 3H-acetylcholine release from superfused hippocampal slices and synaptosomes* (1988) (0)
- Studies on some new indirect dopaminergic receptor agonists (1988) (0)
- Cholinergic regulation of dopamine release in rat corpus striatum after hemitransection of the nigrostriatal pathways or kainic acid injection (1987) (0)
- Presynaptic Muscarinic Receptors: Change of Sensitivity During Long-Term Drug Treatment (1986) (0)
- Inhibition of 5-hydroxytryptamine release by presynaptic alpha2 adrenergic heteroreceptors in human cerebral cortex (1990) (0)
- Presynaptic interactions between acetylcholine and glycine in the human brain. (1996) (0)
- GABAA and glycine strychnine-sensitive receptor modulate NMDA-evoked acetylcholine release from rat spinal motor neurons: A possible role in neuroprotection (2002) (0)
- Mechanisms Underlying the Modulation of Dopamine Release through Presynaptic Muscarinic Receptors (1986) (0)
- Modulation of presynaptic glutamate release: Implications for mood disorders and therapy (2006) (0)
- MODULATE NEUROTRANSMITTERS RELEASE FROM STRIATAL SYNAPTOSOMES (2007) (0)
- Pharmacological characterization of the muscarinic receptors which modulate the release of endogenous glutamate and aspartate in rat hippocampus (1990) (0)
- In vitro release of somatostatin from rat cerebral cortex synaptosomes and slices (1988) (0)
- Regulation of endogenous GABA release through a subtyype of presynaptic α2-adrenoceptor pharmacologically different from α2-autoreceptors* (1988) (0)
- NMDA and non-NMDA receptors coexsist on hippocampal axon terminals and cooperate to enhance 63H9NA release (1992) (0)
- Study on the functional roles of RANTES on glutamate transmission in human and EAE mice brains (2011) (0)
- Glutamate induces SRIF-LI release through the activation of both NMDA and non-NMDA receptors from hippocampal neurons (1995) (0)
- GabaB autoreceptor regulates 3H-Gaba and endogenous GABA release from rat cerebral cortex synaptosomes* (1988) (0)
- [Passive permeability to glycerol in the study of changes induced by various experimental conditions in the synaptosomal membrane]. (1973) (0)
- LACK OF EVIDENCE FOR IN VIVO NO-MEDIATED CGMP SYNTHESIS BY NMDA RECEPTOR ACTIVATION IN THE CEREBRAL CORTEX OF FREELY- MOVING RATS (2003) (0)
- Autoregulation of Dopamine Synthesis in Striatal Nerve Endings (1982) (0)
- 20. Microdialysis study in vivo of the nitric oxide/cGMP pathway in the hippocampus and cerebellum of adult and aged rats (2017) (0)
- Microdialysis in parkinsonian patient basal ganglia: apomorphine effect without changes in the release of neuroactive amino acids (2000) (0)
- Synaptosomal exchange of gaba can simulate high affinity uptake (1975) (0)
- Modulation of dopamine release from the nerve endings of the tubero hypophyseal system (1980) (0)
- Presynaptic D-2 dopamine receptor regulating endogenous glutamate release from rat striatal synaptosomes* (1988) (0)
- IV Inter-regional Meeting of the Liguria, Lombardia, Piemonte Valle d'Aosta Group of the Italian Pharmacological Society. Genoa, 2 February, 1990. (1990) (0)
- 986 – SELECTIVE REGIONAL EFFECTS OF d-AMPHETAMINE ON THE RELEASE OF BIOGENIC AMINES FROM SYNAPTOSOMES (1977) (0)
This paper list is powered by the following services:
